These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 526304)

  • 21. Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
    Tobias JS; Parker LM; Tattersall MH; Frei E
    Br J Cancer; 1975 Aug; 32(2):199-207. PubMed ID: 1212350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adriamycin entrapped by sulfatide-containing liposomes on ovarian tumor-bearing nude mice.
    Kojima N; Ueno N; Takano M; Yabushita H; Noguchi M; Ishihara M; Yagi K
    Biotechnol Appl Biochem; 1986 Oct; 8(5):471-8. PubMed ID: 3768148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro interaction of L1210 cells with phospholipid vesicles.
    Jansons VK; Weis P; Chen T; Redwood WR
    Cancer Res; 1978 Mar; 38(3):530-5. PubMed ID: 564235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of daunomycin and adriamycin in mice. A comparative study.
    Rosso R; Esposito M; Sala R; Santi L
    Biomedicine; 1973 Jul; 19(7):304-7. PubMed ID: 4593553
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-ray repair replication in L1210 leukemia cells.
    Lee YC; Byfield JE; Bennett LR; Chan YM
    Cancer Res; 1974 Oct; 34(10):2624-33. PubMed ID: 4472428
    [No Abstract]   [Full Text] [Related]  

  • 27. Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages.
    Gosálvez M; Blanco MF; Vivero C; Vallés F
    Eur J Cancer (1965); 1978 Nov; 14(11):1185-90. PubMed ID: 216553
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.
    Egorin MJ; Clawson RE; Ross LA; Bachur NR
    Cancer Res; 1980 Jun; 40(6):1928-33. PubMed ID: 7371027
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of cationic liposomes of [3H]thymidine incorporation into DNA of L1210 cells.
    Laurent G; Laduron C; Ruysschaert JM; Deleers M
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):515-27. PubMed ID: 7255883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cholesterol content of liposomes on the encapsulation, efflux and toxicity of adriamycin.
    Ganapathi R; Krishan A
    Biochem Pharmacol; 1984 Feb; 33(4):698-700. PubMed ID: 6704191
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of adriamycin on the reproductive integrity of cultured leukemia L1210 and P388 cells.
    Wilkott LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1978 May; 60(5):1117-20. PubMed ID: 565414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of tetraphenylporphinesulfonate and tetracarboxyphenylporphine in tumor-bearing mice.
    Musser DA; Wagner JM; Datta-Gupta N
    J Natl Cancer Inst; 1978 Dec; 61(6):1397-403. PubMed ID: 281547
    [No Abstract]   [Full Text] [Related]  

  • 35. L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.
    Geroni C; Pesenti E; Broggini M; Belvedere G; Tagliabue G; D'Incalci M; Pennella G; Grandi M
    Br J Cancer; 1994 Feb; 69(2):315-9. PubMed ID: 8297727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmokinetics of 2'-deoxycoformycin in normal and L1210 leukemic mice.
    McConnell WR; Furner RL; Hill DL
    Drug Metab Dispos; 1979; 7(1):11-3. PubMed ID: 35319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of liposomes as carriers of therapeutic agents.
    Mayhew E; Rustum YM
    Prog Clin Biol Res; 1985; 172B():301-10. PubMed ID: 3887426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells.
    Levin M; Silber R; Israel M; Goldfeder A; Khetarpal VK; Potmesil M
    Cancer Res; 1981 Mar; 41(3):1006-10. PubMed ID: 7459847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
    Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
    Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
    Gokhale PC; Radhakrishnan B; Husain SR; Abernethy DR; Sacher R; Dritschilo A; Rahman A
    Br J Cancer; 1996 Jul; 74(1):43-8. PubMed ID: 8679456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.